| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
459,556 |
387,479 |
$61.67M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
206,128 |
173,700 |
$29.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
139,913 |
126,219 |
$25.99M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
62,693 |
52,867 |
$22.97M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
145,633 |
125,633 |
$18.47M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
93,042 |
86,497 |
$14.84M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
91,168 |
84,143 |
$14.71M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
59,418 |
49,097 |
$12.84M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
385,542 |
279,658 |
$10.44M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
67,301 |
61,637 |
$9.49M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
27,304 |
17,801 |
$8.62M |
| J2350 |
Injection, ocrelizumab, 1 mg |
1,025 |
956 |
$8.48M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
34,956 |
32,428 |
$7.29M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
54,300 |
51,087 |
$6.54M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
4,374 |
3,337 |
$6.10M |
| 96415 |
|
10,630 |
8,782 |
$5.60M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
78,308 |
69,922 |
$5.13M |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
29,086 |
27,977 |
$4.94M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
32,691 |
31,016 |
$4.59M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
7,013 |
6,867 |
$4.56M |
| G0378 |
Hospital observation service, per hour |
36,263 |
28,141 |
$4.29M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26,056 |
20,795 |
$4.28M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
25,295 |
24,196 |
$3.91M |
| S9485 |
Crisis intervention mental health services, per diem |
6,871 |
4,684 |
$3.59M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
4,726 |
4,646 |
$3.55M |
| 77386 |
|
15,645 |
1,411 |
$3.55M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
11,181 |
8,350 |
$3.30M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
26,880 |
22,441 |
$3.21M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
4,785 |
4,694 |
$3.12M |
| 70450 |
Computed tomography, head or brain; without contrast material |
23,396 |
21,594 |
$2.96M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
16,962 |
16,333 |
$2.81M |
| 20610 |
|
17,169 |
14,701 |
$2.48M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18,626 |
18,041 |
$2.47M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
32,644 |
31,699 |
$2.47M |
| J9271 |
Injection, pembrolizumab, 1 mg |
569 |
455 |
$2.36M |
| 43235 |
|
2,973 |
2,888 |
$2.01M |
| 76770 |
|
12,251 |
11,935 |
$1.94M |
| J2357 |
Injection, omalizumab, 5 mg |
2,342 |
1,433 |
$1.88M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14,312 |
13,840 |
$1.87M |
| 77412 |
|
12,356 |
1,274 |
$1.84M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,133 |
3,416 |
$1.83M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
18,757 |
17,735 |
$1.82M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15,565 |
13,655 |
$1.74M |
| 36430 |
|
5,530 |
3,423 |
$1.64M |
| J9312 |
Injection, rituximab, 10 mg |
834 |
456 |
$1.60M |
| 76830 |
Ultrasound, transvaginal |
16,023 |
15,445 |
$1.58M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
32,814 |
32,504 |
$1.53M |
| 92587 |
|
12,308 |
12,176 |
$1.49M |
| 97803 |
|
19,349 |
18,274 |
$1.45M |
| 52000 |
|
2,474 |
2,396 |
$1.42M |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
1,500 |
1,472 |
$1.40M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
314,861 |
246,060 |
$1.38M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
15,391 |
14,659 |
$1.38M |
| 62323 |
|
2,830 |
2,747 |
$1.32M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
17,817 |
10,259 |
$1.30M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12,530 |
11,802 |
$1.29M |
| 31575 |
|
7,143 |
6,868 |
$1.28M |
| 93971 |
|
8,270 |
7,686 |
$1.27M |
| 96402 |
|
2,091 |
1,942 |
$1.27M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
905 |
659 |
$1.25M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
5,663 |
5,369 |
$1.22M |
| 20611 |
|
3,936 |
3,294 |
$1.21M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
654 |
640 |
$1.20M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,479 |
8,237 |
$1.19M |
| 59025 |
Fetal non-stress test |
4,208 |
2,693 |
$1.17M |
| 64493 |
|
2,026 |
1,915 |
$1.16M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,488 |
12,346 |
$1.16M |
| 44970 |
|
356 |
349 |
$1.16M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
7,003 |
5,501 |
$1.15M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
34,831 |
28,788 |
$1.14M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
22,740 |
14,368 |
$1.12M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,758 |
1,722 |
$1.09M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
990 |
974 |
$1.08M |
| 70496 |
|
5,374 |
5,113 |
$1.05M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
17,902 |
17,725 |
$1.04M |
| 11102 |
|
2,756 |
2,608 |
$1.04M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
58,713 |
51,649 |
$1.03M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,759 |
2,643 |
$1.03M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,734 |
8,782 |
$1.02M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
38,633 |
37,241 |
$1.01M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
38,624 |
37,233 |
$1.01M |
| 76642 |
|
11,238 |
9,819 |
$1.00M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
877 |
865 |
$997K |
| 71046 |
Radiologic examination, chest; 2 views |
75,597 |
70,587 |
$984K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,228 |
11,016 |
$981K |
| 93975 |
|
10,812 |
10,327 |
$978K |
| 95886 |
|
4,882 |
4,652 |
$951K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
11,292 |
11,047 |
$913K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,923 |
2,686 |
$903K |
| A0425 |
Ground mileage, per statute mile |
95,320 |
79,078 |
$894K |
| 99215 |
Prolong outpt/office vis |
6,294 |
5,899 |
$882K |
| 96367 |
|
4,895 |
3,707 |
$859K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,207 |
1,061 |
$846K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16,059 |
14,160 |
$843K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
6,300 |
6,240 |
$839K |
| 93308 |
|
4,326 |
4,090 |
$818K |
| 64483 |
|
1,638 |
1,601 |
$808K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,929 |
8,771 |
$793K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
1,522 |
1,492 |
$790K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
9,938 |
8,095 |
$781K |
| Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
619 |
222 |
$769K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
1,549 |
1,498 |
$759K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
9,845 |
9,653 |
$753K |
| 76536 |
|
7,381 |
7,219 |
$748K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
44,891 |
40,576 |
$748K |
| V5261 |
Hearing aid, digital, binaural, bte |
795 |
777 |
$731K |
| 29075 |
|
3,293 |
2,799 |
$723K |
| 97802 |
|
9,523 |
9,301 |
$721K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,191 |
5,083 |
$705K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
1,405 |
454 |
$702K |
| 52356 |
|
264 |
249 |
$702K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
175 |
168 |
$702K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,089 |
4,006 |
$660K |
| ATP14 |
|
73,415 |
58,164 |
$635K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
5,871 |
5,383 |
$626K |
| 92557 |
|
10,684 |
10,525 |
$614K |
| 84443 |
Thyroid stimulating hormone (TSH) |
64,613 |
62,167 |
$606K |
| 93325 |
|
6,843 |
6,539 |
$597K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
592 |
422 |
$592K |
| 92567 |
|
19,984 |
19,605 |
$586K |
| 97165 |
|
7,824 |
7,453 |
$568K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
8,403 |
7,668 |
$559K |
| 76801 |
|
5,826 |
5,509 |
$556K |
| 71250 |
|
7,735 |
7,505 |
$555K |
| J0185 |
Injection, aprepitant, 1 mg |
2,985 |
1,931 |
$553K |
| 31231 |
|
2,960 |
2,836 |
$550K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33,625 |
32,787 |
$545K |
| 93017 |
|
6,509 |
6,321 |
$541K |
| ATP08 |
|
76,734 |
60,181 |
$540K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,669 |
10,770 |
$540K |
| 77336 |
|
8,332 |
3,575 |
$537K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,989 |
3,794 |
$526K |
| J0248 |
Injection, remdesivir, 1 mg |
1,649 |
466 |
$506K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
7,160 |
4,184 |
$500K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
48,470 |
38,559 |
$498K |
| 17110 |
|
3,094 |
2,871 |
$496K |
| 95816 |
|
2,200 |
2,067 |
$487K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,186 |
3,154 |
$487K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
97,886 |
94,561 |
$480K |
| V5160 |
Dispensing fee, binaural |
980 |
957 |
$461K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
66,048 |
56,185 |
$460K |
| 12001 |
|
2,110 |
2,037 |
$453K |
| 84484 |
|
67,838 |
44,087 |
$445K |
| 76882 |
|
4,795 |
4,387 |
$441K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,005 |
997 |
$433K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,134 |
2,860 |
$413K |
| J1756 |
Injection, iron sucrose, 1 mg |
7,345 |
2,898 |
$404K |
| J0178 |
Injection, aflibercept, 1 mg |
462 |
360 |
$402K |
| 58300 |
|
2,016 |
1,966 |
$400K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
21,441 |
20,934 |
$399K |
| 76813 |
|
3,531 |
3,492 |
$392K |
| 80053 |
Comprehensive metabolic panel |
190,235 |
153,839 |
$388K |
| 90686 |
|
35,913 |
34,810 |
$384K |
| J3490 |
Unclassified drugs |
5,489 |
3,809 |
$382K |
| 11104 |
|
863 |
827 |
$365K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
1,924 |
932 |
$359K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
68,062 |
62,516 |
$356K |
| 47562 |
|
131 |
122 |
$355K |
| 12011 |
|
1,594 |
1,556 |
$350K |
| 96411 |
|
1,759 |
1,144 |
$346K |
| 19083 |
|
431 |
401 |
$344K |
| 58100 |
|
1,612 |
1,563 |
$343K |
| 10060 |
|
1,955 |
1,843 |
$343K |
| 93970 |
|
1,873 |
1,779 |
$339K |
| 86480 |
|
8,441 |
8,185 |
$337K |
| 70491 |
|
2,473 |
2,379 |
$337K |
| D1208 |
Topical application of fluoride, excluding varnish |
15,286 |
14,610 |
$336K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
140,859 |
123,432 |
$334K |
| A0433 |
Advanced life support, level 2 (als 2) |
794 |
776 |
$331K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
76,285 |
73,269 |
$330K |
| 88185 |
|
1,769 |
1,597 |
$330K |
| 93271 |
|
4,707 |
4,603 |
$321K |
| 93321 |
|
2,710 |
2,654 |
$319K |
| 95819 |
|
1,168 |
1,115 |
$311K |
| 29700 |
|
1,470 |
1,443 |
$310K |
| 73564 |
|
21,123 |
16,561 |
$307K |
| 11900 |
|
1,626 |
1,559 |
$306K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
6,795 |
6,697 |
$306K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
196,136 |
156,381 |
$303K |
| 83735 |
|
87,266 |
58,831 |
$302K |
| 77300 |
|
2,205 |
1,984 |
$300K |
| 81025 |
|
54,049 |
49,485 |
$299K |
| 86850 |
|
46,927 |
38,596 |
$296K |
| 87631 |
|
2,954 |
2,817 |
$290K |
| 77062 |
|
3,795 |
3,749 |
$288K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
20,800 |
17,507 |
$287K |
| 85027 |
|
73,677 |
62,851 |
$286K |
| 96900 |
|
5,897 |
1,033 |
$282K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,677 |
3,490 |
$282K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
1,206 |
1,178 |
$281K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
22,782 |
9,650 |
$277K |
| 84702 |
|
21,977 |
17,365 |
$274K |
| 76870 |
|
3,192 |
3,060 |
$272K |
| 29405 |
|
1,498 |
1,141 |
$272K |
| 95070 |
|
756 |
738 |
$271K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
4,551 |
4,457 |
$270K |
| 90651 |
|
4,428 |
4,272 |
$270K |
| 87536 |
|
6,004 |
5,783 |
$267K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
25,710 |
10,026 |
$267K |
| J0897 |
Injection, denosumab, 1 mg |
567 |
539 |
$264K |
| Q0222 |
Injection, bebtelovimab, 175 mg |
309 |
268 |
$263K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
215 |
207 |
$262K |
| 87088 |
|
48,199 |
44,727 |
$261K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12,135 |
11,878 |
$259K |
| 49083 |
|
735 |
372 |
$257K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
26,074 |
20,698 |
$255K |
| D1351 |
Sealant - per tooth |
22,475 |
3,279 |
$255K |
| 82728 |
|
31,197 |
29,696 |
$254K |
| 96416 |
|
1,713 |
969 |
$254K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
44,785 |
35,988 |
$253K |
| 90715 |
|
13,194 |
12,862 |
$252K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
115 |
86 |
$251K |
| 77065 |
Tomosynthesis, mammo |
5,872 |
5,474 |
$251K |
| 64615 |
|
1,001 |
978 |
$251K |
| 77080 |
|
4,649 |
4,533 |
$249K |
| 58558 |
|
216 |
212 |
$248K |
| 73630 |
|
27,160 |
22,097 |
$247K |
| 93880 |
|
3,056 |
2,944 |
$245K |
| J1453 |
Injection, fosaprepitant, 1 mg |
624 |
397 |
$241K |
| 96127 |
|
4,872 |
4,858 |
$240K |
| 97161 |
|
4,815 |
4,395 |
$237K |
| 86003 |
|
3,158 |
3,023 |
$229K |
| 83690 |
|
49,317 |
44,171 |
$225K |
| J9310 |
Injection, rituximab, 100 mg |
346 |
214 |
$224K |
| 73610 |
|
21,187 |
18,028 |
$223K |
| 95813 |
|
478 |
468 |
$222K |
| 94060 |
|
3,146 |
3,041 |
$216K |
| 77061 |
|
2,690 |
2,641 |
$215K |
| 96409 |
|
1,434 |
854 |
$212K |
| 58661 |
|
102 |
92 |
$210K |
| 83880 |
|
12,969 |
11,916 |
$208K |
| 86803 |
|
22,966 |
22,320 |
$207K |
| 87480 |
|
13,320 |
12,815 |
$204K |
| 87510 |
|
13,321 |
12,818 |
$204K |
| 87660 |
|
13,299 |
12,796 |
$203K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
421 |
409 |
$202K |
| 73030 |
|
19,158 |
16,753 |
$202K |
| ATP15 |
|
27,171 |
20,518 |
$202K |
| 77072 |
|
1,797 |
1,754 |
$202K |
| 94010 |
|
5,501 |
5,233 |
$201K |
| 74178 |
|
1,350 |
1,321 |
$201K |
| 10005 |
|
779 |
742 |
$199K |
| 73130 |
|
21,968 |
16,027 |
$194K |
| 70498 |
|
5,071 |
4,827 |
$193K |
| 81513 |
|
1,847 |
1,794 |
$188K |
| 58301 |
|
1,032 |
1,006 |
$184K |
| 80050 |
General health panel |
11,960 |
11,399 |
$184K |
| 72100 |
|
14,364 |
13,933 |
$183K |
| 92579 |
|
3,964 |
3,928 |
$183K |
| 83605 |
|
25,507 |
17,689 |
$181K |
| 84466 |
|
24,438 |
23,079 |
$179K |
| 76820 |
|
4,160 |
1,879 |
$178K |
| 11981 |
|
559 |
545 |
$176K |
| 93296 |
|
6,214 |
5,961 |
$174K |
| 82607 |
|
22,418 |
21,703 |
$173K |
| 12002 |
|
840 |
819 |
$173K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,173 |
1,131 |
$172K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
69,722 |
57,007 |
$171K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,853 |
13,397 |
$167K |
| 77334 |
|
1,423 |
1,171 |
$166K |
| 93922 |
|
3,469 |
3,359 |
$166K |
| 87522 |
Neg quan hep c or qual rna |
5,980 |
5,628 |
$166K |
| 29705 |
|
800 |
771 |
$164K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
76,872 |
61,134 |
$164K |
| 77066 |
Tomosynthesis, mammo |
5,514 |
5,409 |
$160K |
| 81001 |
|
79,062 |
72,335 |
$160K |
| 73110 |
|
17,315 |
13,410 |
$160K |
| 85610 |
|
84,844 |
52,169 |
$158K |
| V5266 |
Battery for use in hearing device |
1,860 |
1,755 |
$156K |
| 69210 |
|
3,433 |
3,250 |
$156K |
| 96368 |
|
2,730 |
1,866 |
$155K |
| 70486 |
|
2,292 |
2,199 |
$154K |
| 64721 |
|
195 |
193 |
$153K |
| 17000 |
|
1,532 |
1,442 |
$150K |
| 77295 |
|
347 |
321 |
$147K |
| 76604 |
|
1,974 |
1,883 |
$147K |
| 78451 |
|
456 |
444 |
$146K |
| 82803 |
|
9,660 |
8,305 |
$144K |
| 83970 |
|
8,849 |
8,474 |
$144K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
859 |
803 |
$143K |
| 92134 |
|
16,738 |
16,026 |
$143K |
| 81511 |
|
1,572 |
1,552 |
$143K |
| 92585 |
|
462 |
451 |
$143K |
| 88307 |
|
3,195 |
2,995 |
$142K |
| 94070 |
|
826 |
800 |
$142K |
| 87040 |
|
19,793 |
10,656 |
$141K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
7,323 |
2,888 |
$140K |
| 52310 |
|
251 |
237 |
$139K |
| 36224 |
|
60 |
60 |
$139K |
| 74230 |
|
1,096 |
1,057 |
$139K |
| D0120 |
Periodic oral evaluation - established patient |
4,739 |
4,671 |
$135K |
| 86317 |
|
13,464 |
12,650 |
$134K |
| 84439 |
|
23,798 |
22,701 |
$134K |
| 97804 |
|
1,648 |
1,593 |
$133K |
| 87340 |
|
18,081 |
17,464 |
$126K |
| 93458 |
|
117 |
106 |
$125K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
57,394 |
45,248 |
$124K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
9,458 |
8,845 |
$123K |
| J3111 |
Injection, romosozumab-aqqg, 1 mg |
285 |
266 |
$123K |
| 92555 |
|
3,315 |
3,275 |
$122K |
| 99385 |
|
1,581 |
1,537 |
$122K |
| 86900 |
|
46,831 |
38,687 |
$121K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
50,772 |
45,615 |
$120K |
| 92015 |
Determination of refractive state |
9,921 |
9,809 |
$119K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
363 |
349 |
$119K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
466 |
440 |
$118K |
| 76942 |
|
2,807 |
2,641 |
$117K |
| 90714 |
|
5,283 |
5,087 |
$115K |
| 73502 |
|
11,199 |
10,527 |
$115K |
| 88341 |
|
6,015 |
5,407 |
$114K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,200 |
3,383 |
$111K |
| J2704 |
Injection, propofol, 10 mg |
65,540 |
51,118 |
$110K |
| 82746 |
|
15,074 |
14,464 |
$110K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
874 |
788 |
$110K |
| 87077 |
|
21,314 |
19,996 |
$107K |
| J1815 |
Injection, insulin, per 5 units |
21,454 |
6,615 |
$106K |
| 76857 |
|
1,381 |
1,340 |
$106K |
| 76886 |
|
854 |
826 |
$106K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,098 |
3,990 |
$105K |
| 84403 |
|
6,418 |
6,072 |
$105K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49,135 |
40,197 |
$105K |
| 86360 |
|
4,809 |
4,644 |
$104K |
| 74018 |
|
5,416 |
4,904 |
$104K |
| 88142 |
|
7,043 |
6,954 |
$103K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
39,226 |
36,310 |
$103K |
| 17311 |
|
319 |
264 |
$103K |
| 93351 |
|
1,579 |
1,543 |
$102K |
| 83655 |
|
9,322 |
9,150 |
$102K |
| 83540 |
|
27,130 |
25,877 |
$102K |
| 81329 |
|
933 |
925 |
$102K |
| 71271 |
|
2,622 |
2,566 |
$101K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,599 |
2,830 |
$101K |
| 0001A |
|
3,332 |
3,070 |
$100K |
| 86140 |
|
32,229 |
30,224 |
$100K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
2,473 |
2,128 |
$100K |
| 88173 |
|
2,513 |
2,148 |
$99K |
| 11100 |
|
414 |
392 |
$99K |
| 88112 |
|
3,510 |
3,233 |
$99K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
816 |
794 |
$99K |
| 84703 |
|
17,358 |
16,438 |
$98K |
| 87186 |
|
17,665 |
16,534 |
$98K |
| 82784 |
|
11,824 |
11,159 |
$97K |
| 82570 |
|
34,777 |
32,644 |
$95K |
| 71045 |
Radiologic examination, chest; single view |
28,712 |
26,132 |
$94K |
| 76775 |
|
1,282 |
1,230 |
$93K |
| 76937 |
|
3,266 |
3,128 |
$92K |
| 82105 |
|
8,611 |
8,320 |
$92K |
| 86901 |
|
46,685 |
38,628 |
$91K |
| 0002A |
|
2,942 |
2,726 |
$91K |
| 72050 |
|
3,538 |
3,452 |
$90K |
| 51700 |
|
455 |
398 |
$89K |
| 94727 |
|
2,683 |
2,590 |
$89K |
| 62321 |
|
165 |
160 |
$89K |
| 73700 |
|
962 |
880 |
$88K |
| 74019 |
|
6,440 |
6,097 |
$86K |
| 92611 |
|
1,215 |
1,175 |
$86K |
| 86762 |
|
6,915 |
6,802 |
$85K |
| 81003 |
|
55,746 |
50,401 |
$84K |
| 74174 |
|
1,211 |
1,152 |
$84K |
| 36415 |
Collection of venous blood by venipuncture |
483,825 |
379,844 |
$84K |
| 86359 |
|
4,809 |
4,644 |
$84K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
5,399 |
3,936 |
$83K |
| 87081 |
|
14,436 |
14,110 |
$83K |
| 58340 |
|
137 |
134 |
$82K |
| J1644 |
Injection, heparin sodium, per 1000 units |
14,777 |
7,243 |
$81K |
| 87497 |
|
6,110 |
2,885 |
$81K |
| 97162 |
|
2,158 |
1,950 |
$81K |
| 94729 |
|
3,835 |
3,710 |
$80K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
150 |
61 |
$80K |
| 90834 |
Psychotherapy, 45 minutes with patient |
914 |
541 |
$80K |
| 75574 |
|
498 |
479 |
$79K |
| 77002 |
|
1,339 |
1,283 |
$78K |
| 62270 |
|
176 |
169 |
$77K |
| 73140 |
|
7,989 |
6,684 |
$77K |
| 86787 |
|
7,177 |
7,037 |
$77K |
| 93226 |
|
2,010 |
1,973 |
$77K |
| ATP17 |
|
10,280 |
8,799 |
$76K |
| 90677 |
|
1,846 |
1,817 |
$76K |
| 80061 |
Lipid panel |
56,929 |
55,428 |
$75K |
| 93225 |
|
1,435 |
1,410 |
$75K |
| 95911 |
|
1,222 |
1,157 |
$75K |
| V5264 |
Ear mold/insert, not disposable, any type |
1,018 |
978 |
$75K |
| 93926 |
|
541 |
509 |
$74K |
| 84153 |
|
9,883 |
9,457 |
$73K |
| 82670 |
|
3,859 |
3,521 |
$73K |
| 87481 |
|
1,865 |
1,812 |
$73K |
| 73080 |
|
7,135 |
6,360 |
$73K |
| 64415 |
|
408 |
396 |
$73K |
| 95117 |
|
3,356 |
1,937 |
$71K |
| 87070 |
|
13,050 |
11,468 |
$71K |
| 73590 |
|
8,984 |
7,639 |
$71K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
301 |
295 |
$70K |
| 72082 |
|
2,031 |
1,983 |
$69K |
| 72110 |
|
2,583 |
2,524 |
$66K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,065 |
1,023 |
$66K |
| 92595 |
|
1,204 |
1,168 |
$64K |
| 87641 |
|
4,553 |
3,310 |
$64K |
| 80074 |
|
2,156 |
2,014 |
$64K |
| 43237 |
|
121 |
120 |
$64K |
| 95912 |
|
910 |
868 |
$64K |
| 86235 |
|
2,047 |
1,897 |
$63K |
| 77387 |
|
4,018 |
429 |
$63K |
| 84146 |
|
4,841 |
4,671 |
$63K |
| 83001 |
|
5,029 |
4,796 |
$63K |
| 43264 |
|
58 |
53 |
$63K |
| 20550 |
|
432 |
396 |
$63K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
55 |
12 |
$62K |
| 86592 |
|
18,700 |
18,217 |
$61K |
| 92582 |
|
1,556 |
1,542 |
$61K |
| ATP03 |
|
21,643 |
18,367 |
$60K |
| 86780 |
|
5,835 |
5,716 |
$60K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13,290 |
8,653 |
$59K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
68,658 |
62,450 |
$59K |
| 26055 |
|
114 |
84 |
$59K |
| 83516 |
|
5,126 |
4,140 |
$58K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
732 |
623 |
$58K |
| 29125 |
|
617 |
568 |
$58K |
| 82043 |
|
21,962 |
21,406 |
$58K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
514 |
499 |
$58K |
| 92553 |
|
1,069 |
1,047 |
$56K |
| 84402 |
|
3,169 |
3,040 |
$56K |
| 88184 |
|
1,800 |
1,605 |
$56K |
| 86704 |
|
7,750 |
7,493 |
$55K |
| 80197 |
|
14,010 |
8,021 |
$55K |
| 96401 |
|
492 |
351 |
$55K |
| 77301 |
|
183 |
175 |
$55K |
| 0124A |
|
2,326 |
2,270 |
$54K |
| 85730 |
|
14,707 |
13,485 |
$53K |
| 90480 |
|
1,519 |
1,513 |
$53K |
| 86038 |
|
7,387 |
6,576 |
$52K |
| 74170 |
|
232 |
226 |
$52K |
| 52332 |
|
141 |
133 |
$52K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13,019 |
11,810 |
$52K |
| 99386 |
|
709 |
681 |
$51K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
2,075 |
994 |
$51K |
| 90670 |
|
8,921 |
8,669 |
$50K |
| 93270 |
|
1,103 |
1,083 |
$50K |
| 85379 |
|
7,315 |
6,933 |
$50K |
| Q3014 |
Telehealth originating site facility fee |
25,690 |
23,101 |
$50K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19,301 |
14,821 |
$50K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18,686 |
13,079 |
$50K |
| 87902 |
|
435 |
422 |
$50K |
| ATP16 |
|
5,912 |
3,799 |
$48K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
21,410 |
15,782 |
$48K |
| ATP10 |
|
7,111 |
6,075 |
$48K |
| 77290 |
|
216 |
185 |
$48K |
| 77280 |
|
298 |
261 |
$47K |
| 83002 |
|
3,596 |
3,331 |
$47K |
| 73090 |
|
7,163 |
5,992 |
$47K |
| 85652 |
|
29,133 |
27,563 |
$47K |
| 99152 |
|
11,263 |
10,616 |
$46K |
| 73562 |
|
6,572 |
5,167 |
$45K |
| 29065 |
|
186 |
156 |
$45K |
| 92133 |
|
5,124 |
5,001 |
$45K |
| 87799 |
|
3,816 |
1,840 |
$44K |
| ATP09 |
|
6,150 |
4,718 |
$44K |
| 81002 |
|
18,241 |
13,567 |
$44K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
5,718 |
4,205 |
$42K |
| 86618 |
|
4,068 |
3,877 |
$42K |
| 86160 |
|
3,330 |
3,115 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,716 |
2,231 |
$42K |
| 76825 |
|
474 |
448 |
$41K |
| 92083 |
|
4,087 |
3,983 |
$41K |
| 97535 |
Self-care/home management training, each 15 minutes |
951 |
775 |
$40K |
| 82962 |
|
125,147 |
67,187 |
$40K |
| 72070 |
|
2,936 |
2,842 |
$40K |
| V5014 |
Repair/modification of a hearing aid |
744 |
705 |
$40K |
| 47563 |
|
13 |
13 |
$40K |
| 64635 |
|
63 |
61 |
$40K |
| 97035 |
|
696 |
433 |
$40K |
| 93923 |
|
702 |
675 |
$40K |
| 95812 |
|
96 |
93 |
$40K |
| 82652 |
|
1,666 |
1,625 |
$39K |
| 73560 |
|
6,784 |
5,719 |
$39K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
466 |
461 |
$39K |
| 11056 |
|
446 |
428 |
$39K |
| 20553 |
|
277 |
262 |
$39K |
| 11721 |
|
3,647 |
3,567 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,566 |
2,370 |
$39K |
| 88342 |
|
9,292 |
8,614 |
$38K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
3,654 |
2,060 |
$38K |
| 92652 |
|
676 |
657 |
$38K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
95 |
67 |
$38K |
| ATP11 |
|
6,228 |
5,422 |
$38K |
| 73552 |
|
5,745 |
5,111 |
$38K |
| 66982 |
|
63 |
59 |
$37K |
| 87517 |
|
1,589 |
1,515 |
$37K |
| 72040 |
|
3,287 |
3,139 |
$36K |
| 83020 |
|
3,472 |
3,305 |
$36K |
| 90739 |
|
1,735 |
1,693 |
$36K |
| 86833 |
|
1,189 |
1,070 |
$36K |
| A9270 |
Non-covered item or service |
30,154 |
13,038 |
$35K |
| 0003A |
|
974 |
948 |
$35K |
| 86923 |
|
3,162 |
2,168 |
$35K |
| 92250 |
|
4,299 |
4,140 |
$35K |
| 88360 |
|
1,488 |
1,339 |
$34K |
| 90691 |
|
1,770 |
1,687 |
$34K |
| 86832 |
|
804 |
732 |
$33K |
| 36902 |
|
12 |
12 |
$33K |
| 11982 |
|
202 |
198 |
$33K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
27,081 |
26,322 |
$33K |
| 82785 |
|
2,966 |
2,813 |
$33K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,606 |
2,115 |
$33K |
| 90656 |
|
1,756 |
1,743 |
$33K |
| 86800 |
|
3,447 |
3,330 |
$33K |
| 57454 |
|
108 |
105 |
$32K |
| 87205 |
|
11,505 |
9,742 |
$32K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
365 |
364 |
$32K |
| 0071A |
|
706 |
704 |
$32K |
| 85018 |
|
17,957 |
16,165 |
$31K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,161 |
2,055 |
$31K |
| 82951 |
|
2,608 |
2,332 |
$31K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
151 |
74 |
$30K |
| 72170 |
|
4,189 |
3,991 |
$30K |
| 87075 |
|
5,734 |
4,692 |
$30K |
| 85045 |
|
9,803 |
8,159 |
$30K |
| 92591 |
|
950 |
948 |
$29K |
| 90717 |
|
669 |
634 |
$29K |
| 84480 |
|
3,063 |
2,944 |
$29K |
| ATP07 |
|
4,399 |
3,921 |
$29K |
| 74221 |
|
265 |
257 |
$29K |
| 99153 |
Mod sedat endo service >5yrs |
8,950 |
8,464 |
$29K |
| 86376 |
|
2,994 |
2,907 |
$29K |
| 42830 |
|
15 |
15 |
$29K |
| 90732 |
|
2,405 |
2,326 |
$28K |
| 82627 |
|
1,728 |
1,687 |
$28K |
| 76519 |
|
622 |
599 |
$28K |
| 57455 |
|
102 |
96 |
$27K |
| 92594 |
|
1,216 |
865 |
$27K |
| 64450 |
|
146 |
140 |
$27K |
| 0053A |
|
868 |
859 |
$27K |
| 84156 |
|
11,662 |
10,453 |
$27K |
| C1769 |
Guide wire |
8,353 |
7,638 |
$27K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
10,351 |
7,183 |
$26K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
4,755 |
3,778 |
$26K |
| 84165 |
|
5,760 |
5,523 |
$26K |
| 83520 |
|
2,151 |
1,981 |
$26K |
| 76827 |
|
516 |
488 |
$26K |
| 0072A |
|
564 |
561 |
$26K |
| 90746 |
|
1,211 |
1,137 |
$25K |
| 10061 |
|
164 |
150 |
$25K |
| 20552 |
|
148 |
144 |
$25K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,725 |
1,697 |
$25K |
| 82378 |
|
2,743 |
2,326 |
$25K |
| 81508 |
|
961 |
951 |
$25K |
| 86708 |
|
3,409 |
3,316 |
$25K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
4,897 |
4,097 |
$25K |
| 36600 |
|
1,835 |
1,650 |
$25K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
290 |
256 |
$25K |
| 80076 |
|
39,033 |
35,435 |
$24K |
| 99201 |
|
268 |
264 |
$24K |
| 95913 |
|
504 |
471 |
$24K |
| 72081 |
|
1,296 |
1,268 |
$24K |
| 99383 |
|
398 |
368 |
$24K |
| 72131 |
|
734 |
698 |
$24K |
| 76885 |
|
101 |
94 |
$24K |
| 69200 |
|
313 |
300 |
$23K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
3,485 |
2,944 |
$23K |
| J1071 |
Injection, testosterone cypionate, 1 mg |
1,511 |
713 |
$23K |
| 90832 |
Psychotherapy, 30 minutes with patient |
541 |
397 |
$23K |
| 86304 |
|
2,349 |
2,057 |
$23K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
26 |
26 |
$23K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
18,697 |
16,671 |
$23K |
| 99381 |
|
288 |
270 |
$23K |
| 96910 |
|
598 |
106 |
$22K |
| 71101 |
|
1,198 |
1,172 |
$22K |
| 84134 |
|
3,593 |
3,432 |
$22K |
| 74246 |
|
135 |
134 |
$22K |
| 86200 |
|
3,028 |
2,974 |
$22K |
| 86147 |
|
545 |
521 |
$22K |
| 86665 |
|
1,649 |
872 |
$22K |
| 92285 |
|
1,412 |
1,316 |
$21K |
| 73523 |
|
1,234 |
1,204 |
$21K |
| J3489 |
Injection, zoledronic acid, 1 mg |
1,328 |
1,255 |
$21K |
| 82677 |
|
1,071 |
1,061 |
$21K |
| 83498 |
|
937 |
910 |
$21K |
| V5267 |
Hearing aid or assistive listening device/supplies/accessories, not otherwise specified |
840 |
757 |
$21K |
| 93304 |
|
55 |
53 |
$20K |
| 77338 |
|
194 |
186 |
$20K |
| 73060 |
|
3,759 |
3,323 |
$20K |
| 83721 |
|
4,183 |
4,096 |
$20K |
| 90632 |
|
1,190 |
1,124 |
$20K |
| 90662 |
|
2,382 |
2,328 |
$20K |
| 77001 |
|
358 |
342 |
$19K |
| 64494 |
|
1,951 |
1,759 |
$19K |
| 84681 |
|
1,595 |
1,509 |
$19K |
| 99397 |
|
604 |
593 |
$19K |
| 70360 |
|
1,059 |
1,028 |
$19K |
| 86225 |
|
2,912 |
2,478 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
958 |
811 |
$19K |
| G0008 |
Administration of influenza virus vaccine |
9,027 |
8,781 |
$19K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
8,143 |
4,497 |
$19K |
| 73000 |
|
1,724 |
1,518 |
$19K |
| ATP02 |
|
4,625 |
4,086 |
$18K |
| ATP18 |
|
2,724 |
2,382 |
$18K |
| ATP04 |
|
3,214 |
2,762 |
$18K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
121 |
116 |
$18K |
| 95910 |
|
242 |
229 |
$18K |
| 64490 |
|
25 |
25 |
$18K |
| 43762 |
|
98 |
89 |
$18K |
| 10022 |
|
127 |
111 |
$18K |
| 73070 |
|
2,812 |
2,340 |
$18K |
| 12032 |
|
269 |
258 |
$17K |
| D1110 |
Prophylaxis - adult |
824 |
552 |
$17K |
| 80177 |
|
2,251 |
2,106 |
$17K |
| 82533 |
|
1,916 |
1,760 |
$17K |
| 97166 |
|
293 |
257 |
$17K |
| 84163 |
|
1,234 |
1,213 |
$17K |
| 91200 |
|
200 |
196 |
$17K |
| 72072 |
|
1,129 |
1,096 |
$17K |
| 99406 |
|
1,464 |
1,399 |
$17K |
| 93280 |
|
850 |
828 |
$17K |
| 90734 |
|
4,018 |
3,884 |
$17K |
| 93298 |
|
766 |
728 |
$17K |
| 85014 |
|
9,376 |
8,198 |
$16K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
306 |
282 |
$16K |
| 93299 |
|
412 |
380 |
$16K |
| J7050 |
Infusion, normal saline solution, 250 cc |
35,454 |
20,490 |
$16K |
| 86336 |
|
1,093 |
1,081 |
$16K |
| 51798 |
|
10,411 |
10,084 |
$16K |
| 51728 |
|
78 |
76 |
$16K |
| 80164 |
|
2,650 |
2,388 |
$16K |
| 86077 |
|
576 |
500 |
$16K |
| 0012A |
|
1,033 |
783 |
$16K |
| 87449 |
|
2,220 |
1,937 |
$16K |
| 84450 |
|
12,840 |
12,054 |
$16K |
| 87338 |
|
1,566 |
1,527 |
$15K |
| 84481 |
|
1,325 |
1,257 |
$15K |
| 82274 |
|
1,553 |
1,532 |
$15K |
| 80069 |
|
12,952 |
11,436 |
$15K |
| 20605 |
|
89 |
84 |
$15K |
| 91322 |
|
442 |
436 |
$15K |
| 86870 |
|
807 |
655 |
$15K |
| 97760 |
|
321 |
246 |
$15K |
| 86920 |
|
1,362 |
1,089 |
$14K |
| 0011A |
|
1,056 |
800 |
$14K |
| 82950 |
|
3,491 |
3,463 |
$14K |
| 0111A |
|
327 |
327 |
$14K |
| 86334 |
|
1,723 |
1,636 |
$14K |
| 83883 |
|
1,312 |
1,219 |
$14K |
| 86431 |
|
3,981 |
3,886 |
$14K |
| 86146 |
|
422 |
405 |
$13K |
| 84305 |
|
937 |
901 |
$13K |
| 82150 |
|
3,259 |
3,013 |
$13K |
| 82330 |
|
1,931 |
1,713 |
$13K |
| 73521 |
|
694 |
681 |
$13K |
| 38222 |
|
45 |
40 |
$13K |
| 74220 |
|
203 |
197 |
$13K |
| 92504 |
|
1,340 |
1,235 |
$12K |
| 25605 |
|
25 |
25 |
$12K |
| 64644 |
|
146 |
142 |
$12K |
| V5275 |
Ear impression, each |
954 |
948 |
$12K |
| 83013 |
|
236 |
231 |
$12K |
| 93978 |
|
150 |
146 |
$12K |
| 95250 |
|
386 |
361 |
$12K |
| 84100 |
|
35,959 |
24,689 |
$12K |
| 0052A |
|
305 |
303 |
$12K |
| 87147 |
|
2,632 |
2,499 |
$12K |
| 99218 |
|
1,662 |
785 |
$12K |
| 97116 |
|
480 |
263 |
$11K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,166 |
1,743 |
$11K |
| 88304 |
|
9,279 |
8,879 |
$11K |
| 78264 |
|
44 |
43 |
$11K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
45 |
24 |
$11K |
| 70480 |
|
199 |
194 |
$11K |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
199 |
183 |
$11K |
| 82565 |
|
18,594 |
17,390 |
$11K |
| 82088 |
|
489 |
449 |
$11K |
| 0112A |
|
233 |
233 |
$11K |
| 64405 |
|
37 |
36 |
$11K |
| 67840 |
|
14 |
12 |
$11K |
| 19081 |
|
13 |
12 |
$11K |
| 92626 |
|
147 |
133 |
$11K |
| 87427 |
|
1,415 |
1,327 |
$11K |
| 89051 |
|
3,099 |
2,483 |
$10K |
| 0031A |
|
379 |
353 |
$10K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
571 |
379 |
$10K |
| 64495 |
|
763 |
729 |
$10K |
| J2785 |
Injection, regadenoson, 0.1 mg |
3,391 |
3,268 |
$10K |
| 86301 |
|
1,066 |
929 |
$10K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
4,473 |
2,544 |
$10K |
| 36901 |
|
12 |
12 |
$10K |
| 82550 |
|
10,216 |
9,010 |
$10K |
| 11730 |
|
148 |
145 |
$10K |
| 91010 |
|
13 |
13 |
$10K |
| 86765 |
|
1,003 |
977 |
$10K |
| 87206 |
|
2,486 |
1,853 |
$10K |
| 86735 |
|
981 |
955 |
$9K |
| 83615 |
|
16,126 |
10,721 |
$9K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
4,543 |
4,266 |
$9K |
| 93320 |
|
1,396 |
1,366 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
305 |
294 |
$9K |
| 84445 |
|
307 |
301 |
$9K |
| 83521 |
|
1,737 |
1,650 |
$9K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,661 |
1,576 |
$9K |
| 96376 |
|
11,076 |
9,177 |
$9K |
| 74328 |
|
287 |
270 |
$9K |
| 0051A |
|
224 |
222 |
$9K |
| 99384 |
|
241 |
227 |
$9K |
| 87045 |
|
1,441 |
1,353 |
$9K |
| 87102 |
|
1,715 |
1,467 |
$9K |
| 94664 |
|
4,537 |
3,538 |
$9K |
| 80179 |
|
2,268 |
2,145 |
$9K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
2,150 |
722 |
$9K |
| 92002 |
|
104 |
103 |
$8K |
| 51705 |
|
38 |
36 |
$8K |
| ATP13 |
|
1,197 |
1,030 |
$8K |
| 74160 |
|
101 |
100 |
$8K |
| 99205 |
Prolong outpt/office vis |
72 |
71 |
$8K |
| 86258 |
|
1,348 |
1,169 |
$8K |
| 90716 |
|
2,164 |
2,116 |
$8K |
| 88302 |
|
1,662 |
1,442 |
$8K |
| 55700 |
|
16 |
16 |
$8K |
| 90633 |
|
4,929 |
4,824 |
$8K |
| 76831 |
|
59 |
58 |
$8K |
| 82140 |
|
959 |
838 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
203 |
193 |
$8K |
| 84270 |
|
571 |
558 |
$8K |
| 92610 |
|
66 |
65 |
$8K |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
156 |
73 |
$7K |
| 86021 |
|
1,151 |
777 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
8,046 |
6,327 |
$7K |
| 83993 |
|
617 |
585 |
$7K |
| 83921 |
|
774 |
755 |
$7K |
| 51600 |
|
26 |
24 |
$7K |
| 84244 |
|
559 |
526 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
9,524 |
9,196 |
$7K |
| 82610 |
|
666 |
635 |
$7K |
| 36593 |
|
105 |
91 |
$7K |
| 82365 |
|
899 |
857 |
$7K |
| 82390 |
|
934 |
903 |
$7K |
| 96523 |
|
449 |
347 |
$7K |
| 87521 |
Neg quan hep c or qual rna |
335 |
320 |
$7K |
| 86580 |
|
1,218 |
1,001 |
$7K |
| 36561 |
|
13 |
13 |
$7K |
| 36589 |
|
25 |
25 |
$7K |
| 27096 |
|
13 |
13 |
$7K |
| 85041 |
|
2,627 |
2,587 |
$6K |
| 94726 |
|
137 |
134 |
$6K |
| 86664 |
|
551 |
536 |
$6K |
| 11103 |
|
210 |
197 |
$6K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
80 |
24 |
$6K |
| 51702 |
|
2,743 |
2,502 |
$6K |
| 95909 |
|
92 |
82 |
$6K |
| 94761 |
|
6,367 |
6,036 |
$6K |
| ATP05 |
|
988 |
893 |
$6K |
| 99402 |
|
681 |
611 |
$6K |
| 81229 |
|
221 |
180 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
19,314 |
11,746 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
15,808 |
12,908 |
$6K |
| 83021 |
|
408 |
376 |
$6K |
| 86039 |
|
860 |
827 |
$6K |
| 0054A |
|
307 |
306 |
$6K |
| 84432 |
|
783 |
745 |
$6K |
| 86255 |
|
901 |
797 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
10,558 |
9,732 |
$6K |
| 88300 |
|
2,060 |
1,991 |
$6K |
| 96112 |
|
252 |
196 |
$6K |
| 74022 |
|
805 |
779 |
$6K |
| 86341 |
|
655 |
349 |
$5K |
| 80175 |
|
910 |
854 |
$5K |
| 84300 |
|
1,665 |
1,519 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
281 |
206 |
$5K |
| 84550 |
|
12,490 |
8,810 |
$5K |
| 83525 |
|
544 |
480 |
$5K |
| 84132 |
|
4,712 |
3,951 |
$5K |
| 77091 |
|
816 |
802 |
$5K |
| 90707 |
|
2,488 |
2,404 |
$5K |
| 84460 |
|
14,270 |
13,399 |
$5K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
2,048 |
788 |
$5K |
| 0073A |
|
108 |
108 |
$5K |
| 99382 |
|
126 |
122 |
$5K |
| J1750 |
Injection, iron dextran, 50 mg |
182 |
94 |
$5K |
| 51784 |
|
24 |
24 |
$5K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
9,802 |
9,145 |
$5K |
| 87116 |
|
788 |
560 |
$5K |
| 86008 |
|
36 |
35 |
$5K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,623 |
2,244 |
$5K |
| 92588 |
|
27 |
27 |
$5K |
| 90685 |
|
1,065 |
1,000 |
$5K |
| 80183 |
|
590 |
560 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
5,235 |
4,858 |
$4K |
| 88720 |
|
986 |
634 |
$4K |
| 17312 |
|
39 |
25 |
$4K |
| 87046 |
|
616 |
581 |
$4K |
| 86705 |
|
511 |
490 |
$4K |
| 43259 |
|
16 |
16 |
$4K |
| 88237 |
|
88 |
80 |
$4K |
| 82103 |
|
475 |
455 |
$4K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
78 |
41 |
$4K |
| 82040 |
|
6,600 |
6,018 |
$4K |
| 92511 |
|
14 |
12 |
$4K |
| 85347 |
|
1,431 |
1,093 |
$4K |
| 29580 |
|
28 |
13 |
$4K |
| 52005 |
|
26 |
25 |
$4K |
| 29823 |
|
12 |
12 |
$4K |
| 0064A |
|
247 |
239 |
$4K |
| 90648 |
|
1,291 |
1,247 |
$4K |
| 82024 |
|
191 |
181 |
$4K |
| 87324 |
|
626 |
602 |
$4K |
| ATP23 |
|
377 |
302 |
$4K |
| 84425 |
|
332 |
319 |
$4K |
| 80047 |
|
4,015 |
3,702 |
$4K |
| 96417 |
|
4,519 |
2,830 |
$4K |
| 86696 |
|
248 |
233 |
$4K |
| 87015 |
|
997 |
709 |
$4K |
| 83010 |
|
460 |
424 |
$4K |
| 82340 |
|
903 |
866 |
$4K |
| 51741 |
|
151 |
145 |
$4K |
| 73660 |
|
229 |
215 |
$3K |
| 95885 |
|
39 |
36 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
5,196 |
4,888 |
$3K |
| 87209 |
|
283 |
263 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,149 |
847 |
$3K |
| 90653 |
|
245 |
242 |
$3K |
| 80178 |
|
881 |
762 |
$3K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
606 |
304 |
$3K |
| 82077 |
|
3,367 |
3,143 |
$3K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
2,194 |
1,782 |
$3K |
| 82397 |
|
339 |
329 |
$3K |
| 83519 |
|
329 |
288 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
975 |
771 |
$3K |
| 90696 |
|
1,612 |
1,567 |
$3K |
| 0154A |
|
90 |
85 |
$3K |
| 82947 |
|
3,798 |
3,450 |
$3K |
| 92700 |
|
27 |
27 |
$3K |
| 82310 |
|
5,237 |
4,640 |
$3K |
| 84520 |
|
7,429 |
6,835 |
$3K |
| 90673 |
|
115 |
115 |
$3K |
| 20600 |
|
13 |
13 |
$3K |
| 17003 |
|
317 |
305 |
$3K |
| 72220 |
|
222 |
216 |
$3K |
| 94760 |
|
3,033 |
2,374 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
18 |
14 |
$3K |
| 92604 |
|
96 |
76 |
$3K |
| 84144 |
|
208 |
132 |
$3K |
| 80165 |
|
434 |
405 |
$3K |
| 88264 |
|
41 |
38 |
$3K |
| 83550 |
|
710 |
679 |
$2K |
| 86695 |
|
244 |
231 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,889 |
1,843 |
$2K |
| 36591 |
|
2,577 |
1,520 |
$2K |
| 86644 |
|
245 |
229 |
$2K |
| 86364 |
|
2,981 |
2,779 |
$2K |
| 84155 |
|
5,342 |
5,110 |
$2K |
| 87210 |
|
569 |
543 |
$2K |
| 73565 |
|
742 |
731 |
$2K |
| 82172 |
|
205 |
201 |
$2K |
| 90473 |
|
4,560 |
4,535 |
$2K |
| 86308 |
|
527 |
503 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
2,098 |
2,066 |
$2K |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
55 |
26 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
89 |
87 |
$2K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
14 |
14 |
$2K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,826 |
941 |
$2K |
| 85576 |
|
132 |
93 |
$2K |
| 88312 |
|
2,048 |
1,932 |
$2K |
| 84157 |
|
907 |
808 |
$2K |
| 78306 |
|
19 |
19 |
$2K |
| 82945 |
|
832 |
746 |
$2K |
| 82248 |
|
4,082 |
3,625 |
$2K |
| 70487 |
|
26 |
24 |
$2K |
| 92540 |
|
54 |
54 |
$2K |
| 0164A |
|
42 |
42 |
$2K |
| 69209 |
|
12 |
12 |
$2K |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
1,210 |
1,134 |
$2K |
| 80143 |
|
2,021 |
1,859 |
$2K |
| 88313 |
|
801 |
729 |
$2K |
| 83718 |
|
301 |
301 |
$2K |
| J9045 |
Injection, carboplatin, 50 mg |
1,368 |
864 |
$2K |
| 80156 |
|
339 |
315 |
$2K |
| 87177 |
|
282 |
262 |
$2K |
| 86141 |
|
278 |
263 |
$2K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
53 |
41 |
$2K |
| G0009 |
Administration of pneumococcal vaccine |
2,468 |
2,385 |
$2K |
| 90620 |
|
70 |
68 |
$2K |
| 76706 |
|
43 |
39 |
$2K |
| 87650 |
|
155 |
152 |
$2K |
| 82247 |
|
1,616 |
1,223 |
$2K |
| D1120 |
Prophylaxis - child |
30 |
29 |
$1K |
| 92593 |
|
67 |
67 |
$1K |
| V5020 |
Conformity evaluation |
24 |
24 |
$1K |
| 92551 |
|
12 |
12 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
2,222 |
1,943 |
$1K |
| 80203 |
|
205 |
190 |
$1K |
| 92556 |
|
26 |
25 |
$1K |
| 85613 |
|
231 |
215 |
$1K |
| 72190 |
|
224 |
215 |
$1K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
128 |
76 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
15,862 |
14,411 |
$1K |
| 82104 |
|
153 |
152 |
$1K |
| 83935 |
|
369 |
320 |
$1K |
| 95874 |
|
541 |
523 |
$1K |
| 86381 |
|
357 |
334 |
$1K |
| 87640 |
|
661 |
373 |
$1K |
| 36592 |
|
2,086 |
1,270 |
$1K |
| 90678 |
|
47 |
47 |
$1K |
| 89060 |
|
348 |
329 |
$1K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
6,640 |
6,152 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
10,379 |
8,785 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
680 |
535 |
$1K |
| 88262 |
|
12 |
12 |
$1K |
| 83835 |
|
117 |
97 |
$1K |
| 82977 |
|
2,259 |
2,101 |
$1K |
| 87625 |
|
153 |
149 |
$1K |
| 93976 |
|
12 |
12 |
$1K |
| 77073 |
|
45 |
41 |
$1K |
| 72080 |
|
43 |
41 |
$1K |
| 84166 |
|
158 |
143 |
$1K |
| J0456 |
Injection, azithromycin, 500 mg |
228 |
155 |
$1K |
| 88230 |
|
12 |
12 |
$1K |
| 73200 |
|
25 |
24 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,577 |
1,486 |
$1K |
| 88311 |
|
1,386 |
1,258 |
$992.05 |
| 76098 |
|
13 |
12 |
$973.30 |
| 88172 |
|
54 |
51 |
$950.16 |
| 76872 |
|
16 |
16 |
$936.46 |
| 84590 |
|
120 |
119 |
$935.06 |
| 51701 |
|
1,905 |
1,835 |
$907.62 |
| 64643 |
|
14 |
12 |
$900.62 |
| 82952 |
|
281 |
279 |
$896.82 |
| 86593 |
|
303 |
290 |
$895.94 |
| 72202 |
|
93 |
93 |
$847.04 |
| 82731 |
|
14 |
14 |
$822.50 |
| 86617 |
|
182 |
84 |
$816.00 |
| 92537 |
|
14 |
14 |
$815.68 |
| 82465 |
|
906 |
870 |
$779.34 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
241 |
192 |
$771.17 |
| 12051 |
|
13 |
13 |
$765.21 |
| 98926 |
|
15 |
13 |
$757.35 |
| 75625 |
|
12 |
12 |
$750.57 |
| 81206 |
|
13 |
12 |
$747.80 |
| 86812 |
|
40 |
40 |
$746.26 |
| 86015 |
|
529 |
472 |
$668.41 |
| 90744 |
|
3,151 |
3,041 |
$649.10 |
| 71100 |
|
26 |
26 |
$630.64 |
| 96111 |
|
467 |
294 |
$629.87 |
| 86922 |
|
54 |
36 |
$624.96 |
| 80185 |
|
128 |
112 |
$624.78 |
| 93312 |
|
12 |
12 |
$612.60 |
| 87255 |
|
27 |
24 |
$583.11 |
| 84446 |
|
65 |
64 |
$582.61 |
| J3411 |
Injection, thiamine hcl, 100 mg |
164 |
94 |
$564.28 |
| V5011 |
Fitting/orientation/checking of hearing aid |
25 |
25 |
$562.16 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,593 |
2,489 |
$557.57 |
| 77081 |
|
12 |
12 |
$540.77 |
| 73100 |
|
104 |
86 |
$531.85 |
| 93229 |
|
12 |
12 |
$522.00 |
| 82507 |
|
26 |
25 |
$507.40 |
| 90636 |
|
74 |
73 |
$504.53 |
| 95249 |
|
12 |
12 |
$487.85 |
| 87329 |
|
53 |
49 |
$474.33 |
| 70250 |
|
41 |
37 |
$472.98 |
| J9267 |
Injection, paclitaxel, 1 mg |
1,317 |
647 |
$471.35 |
| C1760 |
Closure device, vascular (implantable/insertable) |
692 |
657 |
$455.54 |
| 86355 |
|
43 |
40 |
$451.50 |
| 82010 |
|
75 |
64 |
$428.14 |
| 64484 |
|
158 |
157 |
$411.30 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
941 |
917 |
$411.01 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
1,758 |
1,620 |
$407.34 |
| 82375 |
|
52 |
49 |
$406.98 |
| 86357 |
|
27 |
26 |
$404.26 |
| 82553 |
|
53 |
50 |
$377.57 |
| 90661 |
|
28 |
28 |
$362.00 |
| A4648 |
Tissue marker, implantable, any type, each |
1,072 |
972 |
$347.94 |
| 83930 |
|
75 |
68 |
$347.74 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
372 |
356 |
$345.56 |
| 80202 |
|
71 |
27 |
$340.88 |
| 82166 |
|
14 |
14 |
$340.60 |
| 87220 |
|
121 |
117 |
$338.83 |
| 90682 |
|
219 |
216 |
$337.79 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
246 |
48 |
$336.96 |
| 98927 |
|
14 |
12 |
$328.01 |
| 75710 |
|
12 |
12 |
$321.67 |
| 80195 |
|
53 |
14 |
$313.25 |
| 82272 |
|
185 |
176 |
$312.99 |
| 82157 |
|
12 |
12 |
$309.84 |
| 92517 |
|
12 |
12 |
$298.21 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,820 |
1,457 |
$297.28 |
| 76376 |
|
3,282 |
3,108 |
$296.61 |
| V2632 |
Posterior chamber intraocular lens |
1,664 |
1,449 |
$286.97 |
| 96377 |
|
803 |
614 |
$274.97 |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
53 |
27 |
$267.98 |
| 76514 |
|
14 |
14 |
$262.36 |
| 82787 |
|
15 |
14 |
$254.52 |
| 82085 |
|
41 |
41 |
$254.18 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
919 |
874 |
$254.02 |
| 86769 |
|
14 |
13 |
$252.78 |
| ATP06 |
|
44 |
39 |
$250.48 |
| 87593 |
|
13 |
12 |
$247.60 |
| 83945 |
|
27 |
26 |
$246.54 |
| 92136 |
|
14 |
14 |
$241.20 |
| 82164 |
|
26 |
26 |
$234.92 |
| 80299 |
|
27 |
24 |
$222.77 |
| 93282 |
|
14 |
13 |
$208.25 |
| 80158 |
|
23 |
12 |
$204.82 |
| A4217 |
Sterile water/saline, 500 ml |
829 |
709 |
$201.51 |
| 82232 |
|
28 |
27 |
$199.97 |
| 36416 |
|
4,935 |
4,572 |
$196.80 |
| 84295 |
|
1,597 |
1,378 |
$185.41 |
| J7510 |
Prednisolone oral, per 5 mg |
193 |
176 |
$182.40 |
| 84206 |
|
12 |
12 |
$177.48 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
1,073 |
981 |
$172.46 |
| 80184 |
|
41 |
38 |
$165.34 |
| 85384 |
|
24 |
24 |
$163.20 |
| 73650 |
|
27 |
25 |
$157.66 |
| 86777 |
|
13 |
12 |
$157.56 |
| 84133 |
|
53 |
51 |
$157.20 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
542 |
327 |
$155.11 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
125 |
70 |
$155.11 |
| 83090 |
|
12 |
12 |
$153.90 |
| 85660 |
|
48 |
36 |
$140.94 |
| 84630 |
|
13 |
13 |
$130.65 |
| 73010 |
|
15 |
14 |
$128.71 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
269 |
157 |
$128.36 |
| J1956 |
Injection, levofloxacin, 250 mg |
226 |
193 |
$128.36 |
| 90713 |
|
87 |
80 |
$125.08 |
| 83986 |
|
57 |
52 |
$120.00 |
| 87807 |
|
13 |
12 |
$118.10 |
| 86709 |
|
14 |
13 |
$116.20 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,654 |
1,524 |
$116.01 |
| J9190 |
Injection, fluorouracil, 500 mg |
2,746 |
1,024 |
$109.08 |
| 84105 |
|
27 |
26 |
$99.12 |
| 84075 |
|
753 |
670 |
$97.80 |
| 99195 |
|
29 |
25 |
$86.80 |
| 84392 |
|
26 |
25 |
$86.60 |
| 84560 |
|
26 |
25 |
$86.60 |
| 90474 |
|
689 |
663 |
$82.39 |
| 90688 |
|
40 |
40 |
$79.40 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
6,374 |
4,431 |
$78.96 |
| 92025 |
|
46 |
44 |
$78.58 |
| 86880 |
|
27 |
26 |
$76.00 |
| 77417 |
|
47 |
29 |
$75.61 |
| 90619 |
|
112 |
104 |
$68.89 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
41 |
34 |
$54.04 |
| 84436 |
|
16 |
16 |
$49.56 |
| 91305 |
|
1,294 |
1,251 |
$47.76 |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
146 |
143 |
$39.20 |
| 89055 |
|
13 |
12 |
$35.20 |
| J2359 |
Injection, olanzapine, 0.5 mg |
194 |
112 |
$27.94 |
| 90710 |
|
1,747 |
1,700 |
$23.88 |
| 81596 |
|
567 |
552 |
$20.00 |
| 84478 |
|
178 |
142 |
$15.54 |
| 73600 |
|
33 |
28 |
$15.11 |
| C9399 |
Unclassified drugs or biologicals |
820 |
312 |
$13.65 |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,893 |
1,826 |
$6.26 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
128 |
126 |
$5.76 |
| 90700 |
|
165 |
154 |
$3.37 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
467 |
450 |
$3.15 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,050 |
1,124 |
$2.58 |
| 81005 |
|
15 |
15 |
$2.24 |
| G0010 |
Administration of hepatitis b vaccine |
454 |
433 |
$1.61 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
820 |
719 |
$0.01 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
824 |
728 |
$0.01 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
892 |
705 |
$0.00 |
| C1776 |
Joint device (implantable) |
57 |
56 |
$0.00 |
| 93356 |
|
750 |
729 |
$0.00 |
| L3913 |
Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
329 |
312 |
$0.00 |
| J7070 |
Infusion, d5w, 1000 cc |
1,784 |
854 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
168 |
166 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
316 |
288 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
235 |
226 |
$0.00 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
3,034 |
1,436 |
$0.00 |
| C1758 |
Catheter, ureteral |
90 |
87 |
$0.00 |
| 81336 |
|
28 |
27 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
1,075 |
1,063 |
$0.00 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
131 |
119 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
125 |
123 |
$0.00 |
| G0390 |
Trauma response team associated with hospital critical care service |
28 |
28 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
84 |
79 |
$0.00 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
182 |
129 |
$0.00 |
| 99188 |
|
97 |
97 |
$0.00 |
| 64491 |
|
25 |
25 |
$0.00 |
| 91300 |
|
5,371 |
4,664 |
$0.00 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
57 |
51 |
$0.00 |
| 91312 |
|
2,116 |
2,058 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
501 |
358 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
82 |
66 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
26 |
26 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
55 |
53 |
$0.00 |
| 80361 |
|
99 |
84 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
26 |
26 |
$0.00 |
| 11101 |
|
31 |
26 |
$0.00 |
| J1245 |
Injection, dipyridamole, per 10 mg |
100 |
59 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
15 |
13 |
$0.00 |
| 80356 |
|
32 |
25 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
47 |
45 |
$0.00 |
| 90687 |
|
19 |
19 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
252 |
117 |
$0.00 |
| 74300 |
|
13 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
156 |
97 |
$0.00 |
| 87469 |
|
156 |
146 |
$0.00 |
| 99157 |
|
28 |
28 |
$0.00 |
| 91321 |
|
18 |
18 |
$0.00 |
| C1729 |
Catheter, drainage |
181 |
159 |
$0.00 |
| 91311 |
|
580 |
572 |
$0.00 |
| 64636 |
|
38 |
37 |
$0.00 |
| 86036 |
|
23 |
21 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
70 |
65 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
16 |
14 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
23 |
23 |
$0.00 |
| 81450 |
|
16 |
12 |
$0.00 |
| L8613 |
Ossicula implant |
26 |
26 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
42 |
40 |
$0.00 |
| 99411 |
|
28 |
27 |
$0.00 |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
37 |
12 |
$0.00 |
| 0042T |
|
15 |
15 |
$0.00 |
| 90698 |
|
5,605 |
5,455 |
$0.00 |
| 90680 |
|
5,122 |
5,002 |
$0.00 |
| 87493 |
|
341 |
310 |
$0.00 |
| 90723 |
|
593 |
575 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
100 |
96 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,796 |
1,615 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,753 |
2,955 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
583 |
549 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
303 |
286 |
$0.00 |
| 91303 |
|
228 |
206 |
$0.00 |
| 96040 |
|
1,290 |
1,255 |
$0.00 |
| C2627 |
Catheter, suprapubic/cystoscopic |
290 |
265 |
$0.00 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
290 |
286 |
$0.00 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
405 |
403 |
$0.00 |
| C1781 |
Mesh (implantable) |
476 |
453 |
$0.00 |
| L3906 |
Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
325 |
309 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
480 |
428 |
$0.00 |
| 87468 |
|
132 |
125 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,081 |
685 |
$0.00 |
| 91307 |
|
1,426 |
1,327 |
$0.00 |
| 89322 |
|
109 |
104 |
$0.00 |
| 91306 |
|
68 |
68 |
$0.00 |
| 87478 |
|
114 |
107 |
$0.00 |
| 91301 |
|
1,231 |
737 |
$0.00 |
| 99156 |
|
41 |
41 |
$0.00 |
| 90697 |
|
645 |
645 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
18 |
13 |
$0.00 |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
114 |
108 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
578 |
566 |
$0.00 |
| L3933 |
Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment |
67 |
64 |
$0.00 |
| J8501 |
Aprepitant, oral, 5 mg |
27 |
26 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
113 |
86 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
346 |
316 |
$0.00 |
| 80051 |
|
18 |
14 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |
| 88309 |
|
13 |
12 |
$0.00 |
| 51797 |
|
43 |
42 |
$0.00 |
| 82435 |
|
61 |
51 |
$0.00 |
| 94644 |
|
119 |
114 |
$0.00 |
| 87484 |
|
131 |
124 |
$0.00 |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
32 |
29 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
35 |
16 |
$0.00 |
| 91315 |
|
45 |
40 |
$0.00 |
| 94660 |
|
18 |
14 |
$0.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
41 |
41 |
$0.00 |
| L3927 |
Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf |
24 |
24 |
$0.00 |
| 95012 |
|
14 |
12 |
$0.00 |
| 49465 |
|
17 |
13 |
$0.00 |
| 0361U |
|
26 |
26 |
$0.00 |
| 72052 |
|
15 |
12 |
$0.00 |
| 64492 |
|
12 |
12 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
26 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
20 |
15 |
$0.00 |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
26 |
26 |
$0.00 |
| 99292 |
|
16 |
15 |
$0.00 |